Biomarin Pharmaceutical Inc (BMRN)
92.04
+2.55
(+2.85%)
USD |
NASDAQ |
Apr 23, 16:00
92.06
+0.02
(+0.02%)
After-Hours: 20:00
Biomarin Pharmaceutical Gross Profit Margin (Quarterly): 79.03% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 79.03% |
| September 30, 2023 | 78.54% |
| June 30, 2023 | 78.48% |
| March 31, 2023 | 78.78% |
| December 31, 2022 | 76.32% |
| September 30, 2022 | 76.99% |
| June 30, 2022 | 76.93% |
| March 31, 2022 | 77.48% |
| December 31, 2021 | 73.38% |
| September 30, 2021 | 74.67% |
| June 30, 2021 | 74.67% |
| March 31, 2021 | 75.28% |
| December 31, 2020 | 72.10% |
| September 30, 2020 | 60.40% |
| June 30, 2020 | 77.19% |
| March 31, 2020 | 77.82% |
| December 31, 2019 | 78.90% |
| September 30, 2019 | 78.97% |
| June 30, 2019 | 80.03% |
| March 31, 2019 | 77.75% |
| December 31, 2018 | 78.76% |
| September 30, 2018 | 79.86% |
| June 30, 2018 | 78.81% |
| March 31, 2018 | 77.95% |
| December 31, 2017 | 78.79% |
| Date | Value |
|---|---|
| September 30, 2017 | 82.20% |
| June 30, 2017 | 82.26% |
| March 31, 2017 | 83.54% |
| December 31, 2016 | 78.62% |
| September 30, 2016 | 81.87% |
| June 30, 2016 | 82.80% |
| March 31, 2016 | 81.79% |
| December 31, 2015 | 78.92% |
| September 30, 2015 | 83.29% |
| June 30, 2015 | 84.78% |
| March 31, 2015 | 84.72% |
| December 31, 2014 | 83.34% |
| September 30, 2014 | 83.05% |
| June 30, 2014 | 83.73% |
| March 31, 2014 | 84.95% |
| December 31, 2013 | 88.24% |
| September 30, 2013 | 79.50% |
| June 30, 2013 | 83.50% |
| March 31, 2013 | 83.98% |
| December 31, 2012 | 79.89% |
| September 30, 2012 | 80.78% |
| June 30, 2012 | 80.99% |
| March 31, 2012 | 85.34% |
| December 31, 2011 | 80.05% |
| September 30, 2011 | 80.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
60.40%
Minimum
Sep 2020
80.03%
Maximum
Jun 2019
76.10%
Average
77.19%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 80.88% |
| Merck & Co Inc | 73.26% |
| Pfizer Inc | 46.92% |
| Bristol-Myers Squibb Co | 76.08% |
| Moderna Inc | 66.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.51% |
| Return on Assets | 2.54% |
| Return on Invested Capital | 2.86% |
| Profit Margin (Quarterly) | 3.15% |
| Operating Margin (Quarterly) | 2.21% |
| Return on Net Operating Assets | 4.81% |